oxidopamine and u 0126
oxidopamine has been researched along with u 0126 in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Klann, E; Lin, E; Perez, RG; Ugarte, SD; Zigmond, MJ | 1 |
Cavanaugh, JE; Jaumotte, JD; Lakoski, JM; Zigmond, MJ | 1 |
Chu, CT; Horbinski, C; Kulich, SM; Patel, M | 1 |
Cavanaugh, JE; Leak, RK; Lin, E; Perez, RG; Zigmond, MJ | 1 |
Greig, NH; Holloway, HW; Li, Y; Mattson, MP; Tweedie, D | 1 |
Cui, C; Ding, HF; Fan, Y; Fu, SB; Jiang, LH; Li, J; Ma, L; Sun, DJ; Yang, J; Zhang, YN | 1 |
Bagetta, V; Brambilla, R; Calabresi, P; Cerovic, M; Fasano, S; Ghiglieri, V; Giampà, C; Hardingham, N; Heuer, A; Marchisella, F; Morella, I; Papale, A; Pendolino, V; Picconi, B | 1 |
Ballerini, P; Buccella, S; Caciagli, F; Ciccarelli, R; D'Alimonte, I; Di Iorio, P; Giuliani, P; Pokorski, M; Rathbone, MP; Romano, S | 1 |
Other Studies
8 other study(ies) available for oxidopamine and u 0126
Article | Year |
---|---|
Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK.
Topics: Animals; Butadienes; Cell Death; Cell Line; Cell Survival; Chromones; Dopamine; Enzyme Inhibitors; Glial Cell Line-Derived Neurotrophic Factor; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Morpholines; Nerve Growth Factors; Neurons; Neuroprotective Agents; Nitriles; Oxidative Stress; Oxidopamine; Parkinson Disease; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Sympatholytics | 2003 |
Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress.
Topics: Blotting, Western; Butadienes; Cell Death; Cell Line; Cell Survival; Culture Media; Dopamine; Enzyme Inhibitors; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Nitriles; Oxidative Stress; Oxidopamine; Plasmids; Transfection | 2006 |
6-Hydroxydopamine induces mitochondrial ERK activation.
Topics: Animals; Butadienes; Catalase; Cells, Cultured; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Metalloporphyrins; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Neurons; Nitriles; Oxidopamine; Rats; Signal Transduction | 2007 |
Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Butadienes; Caspase 3; Cell Line, Transformed; Cell Survival; CREB-Binding Protein; Dopamine; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Mice; Mice, Inbred C57BL; Neurons; Nitriles; Oxidopamine; Phosphorylation; Reactive Oxygen Species; Time Factors | 2008 |
Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Topics: Activating Transcription Factor 4; Adrenergic Agents; Apoptosis; bcl-2-Associated X Protein; Bromodeoxyuridine; Butadienes; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Neuroblastoma; Neuroprotective Agents; Nitriles; Oxidants; Oxidopamine; Peptides; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucagon; Signal Transduction; Time Factors; Transfection; Venoms | 2010 |
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.
Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow Cytometry; Humans; Indicators and Reagents; Indoles; MAP Kinase Signaling System; Nitriles; Oxidopamine; Parkinson Disease; PC12 Cells; Phenols; Phosphorylation; Proto-Oncogene Proteins c-raf | 2012 |
Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
Topics: Animals; Antiparkinson Agents; Butadienes; Cerebral Cortex; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Extracellular Signal-Regulated MAP Kinases; Levodopa; Mice, Knockout; Neuronal Plasticity; Neurons; Nitriles; Oxidopamine; Parkinsonian Disorders; Protein Kinase Inhibitors; ras-GRF1; Tissue Culture Techniques | 2015 |
Guanosine protects glial cells against 6-hydroxydopamine toxicity.
Topics: Animals; Apoptosis; Astrocytes; Biological Transport; Butadienes; Cell Line, Tumor; Chromones; DNA Fragmentation; Drug Evaluation, Preclinical; Glioma; Guanosine; In Vitro Techniques; MAP Kinase Signaling System; Morpholines; Neuroprotective Agents; Neurotoxins; Nitriles; Nucleoside Transport Proteins; Oxidopamine; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2015 |